Metraipolis › archive › dc_cee018cfcaf6

Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41305005
DOI
10.3390/ph18111764
License (as archived)
solo-consultazione
Archived
2026-11-08T09:38:24.085Z
SHA-256 of the archived text
b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932
Stable URL of this page
https://metraipolis.com/documento/dc_cee018cfcaf6

How to cite

Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005 — Europe PMC (en), https://europepmc.org/article/MED/41305005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cee018cfcaf6 (Metraipolis archive dc_cee018cfcaf6, sha256 b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932)
BibTeX
@misc{dccee018cfcaf6,
  title = {Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types — Europe PMC PMID:41305005},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41305005},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cee018cfcaf6; sha256 b1a2882b0b1fae402cd9a2a8db3ca73c2dc80ffabf4f056995bfc9086508b932},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41305005. Agents can read the archived copy with the MCP tool read_document.